Press Releases enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
4.89 ^USD	+2.95%		+1.45%	-4.86%

May. 08	EnVVeno Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 16	EnVVeno Medical Corporation Announces Additional Topline Efficacy Data from the VenoValve U.S. Pivotal Trial to Be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EnVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update	May. 09	AQ
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium	Apr. 25	AQ
New Topline Efficacy Data from the enVVeno Medical VenoValve Pivotal Trial to be presented at the 46th Annual Charing Cross Symposium on April 24, 2024	Apr. 17	AQ
EnVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer	Apr. 10	AQ
EnVVeno Medical : Corporate Presentation	Apr. 10	PU
EnVVeno Medical : Corporate Presentation	Apr. 02	PU
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting	Mar. 07	AQ
EnVVeno Medical : Corporate Presentation	Mar. 04	PU
EnVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update	Mar. 01	AQ
Topline Efficacy Data from the enVVeno Medical VenoValve Pivotal Trial to be presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024	Feb. 21	AQ
EnVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium	Dec. 15	AQ
EnVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium	Nov. 17	AQ
EnVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate Update	23-10-27	AQ
EnVVeno Medical : Corporate Presentation	23-10-10	PU
EnVVeno Medical Announces New Expedited Development Plan for the enVVe Transcatheter Based Replacement Venous Valve	23-10-09	AQ
EnVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial	23-10-09	AQ
EnVVeno Medical Announces Private Placement of $28 Million	23-10-09	AQ
EnVVeno Medical : Corporate Presentation	23-08-17	PU
Note 2 - Management's Liquidity Plan	23-04-28	AQ
ENVVENO MEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Press Releases

Filters